Rare diseases
Investigational molecules
Locations
Back to Germany1 444 clinical trials in Hochheim Am Main, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)ICP-332 for Adults with Prurigo Nodularis
GermanyRO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes
GermanyA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
GermanyA study to evaluate the effectiveness and safety of eloralintide in adults with obesity or overweight without type 2 diabetes.
GermanyA study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism
GermanyA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
GermanyA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
GermanyA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
GermanyA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
GermanyA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
GermanyStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
GermanyStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Gaucher disease and Niemann-Pick disease, exploring new therapeutic approaches for these challenging genetic conditions. Studies aim to evaluate novel treatments for improving neurological symptoms and overall patient outcomes.
Clinical investigations evaluating venglustat and nizubaglustat's effectiveness in managing disease progression.
Research centered on treating Mucopolysaccharidosis Type II (Hunter Syndrome) and Pompe disease, with multiple studies investigating innovative enzyme replacement therapies and novel drug combinations.
Evaluation of treatments like JR-141 and cipaglucosidase alfa for improved patient outcomes.
Studies focused on preventing respiratory syncytial virus infections in older adults, with particular attention to vaccine development and immune response assessment.
Investigation of revaccination strategies and long-term protection against respiratory infections.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
